Drug Delivery Technology

INNSBRUCK, Austria — September 29, 2026 Cyprumed GmbH announced that MSD has initiated a Phase 1 clinical trial of...

Wuxi, China, September 2, 2026 Norroy Bioscience has received regulatory clearance from China’s National Medical Products Administration (NMPA) to...

Daejeon, South Korea, September 2, 2026 Alteogen Inc. has entered into an option and license agreement with Novartis to...

Rockville, Maryland and Shanghai, China, August 17, 2026 AbelZeta Pharma, Inc. announced that the U.S. Food and Drug Administration...

Bedford, Massachusetts, August 14, 2026 Lantheus Holdings, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved...

San Diego, California, August 14, 2026 BioSapien Inc., a biotechnology company developing localized drug-delivery technologies for cancer treatment, has...

Waltham, Massachusetts, July 28, 2026 Dyne Therapeutics has announced that the U.S. Food and Drug Administration (FDA) has cleared...

Mequon, Wisconsin & Lenexa, Kansas, July 28, 2026 Vector Science & Therapeutics Corp., LyoGenesis Plus 1, LLC, and Wynn...

Ramat-Gan, Israel, July 28, 2026 Galmed Pharmaceuticals Ltd. has announced a significant advancement in the development of Aramchol orally...

NEW HAVEN, Conn., July 20, 2026 Biohaven Ltd. has announced that new Phase I clinical data for BHV-1530, its...